Jiangsu Kanion Pharmaceutical Co Ltd (600557) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥201.83 Million ≈ $29.53 Million USD) by net assets (CN¥4.91 Billion ≈ $718.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Kanion Pharmaceutical Co Ltd (600557) net asset quality to measure how much of total assets are equity-financed.
Jiangsu Kanion Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Jiangsu Kanion Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Jiangsu Kanion Pharmaceutical Co Ltd (600557) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Jiangsu Kanion Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Kanion Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Huafa Industrial Co Ltd Zhuhai
SHG:600325
|
0.074x |
|
Shenzhen Terca Technology Co Ltd
SHE:002213
|
-0.254x |
|
Sichuan Xunyou Network Technology Co Ltd
SHE:300467
|
0.041x |
|
Sinostone Guangdong Co Ltd
SHE:001212
|
0.011x |
|
Blue Square Real Estate Ltd
TA:BLSR
|
0.025x |
|
Phoenix Education Partners, Inc.
NYSE:PXED
|
0.167x |
|
Sihui Fuji Electronics Technology Co Ltd
SHE:300852
|
0.026x |
|
Boozt AB
ST:BOOZT
|
0.379x |
Annual Cash Flow Conversion Efficiency for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Jiangsu Kanion Pharmaceutical Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.71 Billion ≈ $688.50 Million |
CN¥702.49 Million ≈ $102.80 Million |
0.149x | -17.38% |
| 2023-12-31 | CN¥5.38 Billion ≈ $787.34 Million |
CN¥972.32 Million ≈ $142.28 Million |
0.181x | -10.47% |
| 2022-12-31 | CN¥4.93 Billion ≈ $722.00 Million |
CN¥995.94 Million ≈ $145.74 Million |
0.202x | -0.60% |
| 2021-12-31 | CN¥4.47 Billion ≈ $654.50 Million |
CN¥908.30 Million ≈ $132.91 Million |
0.203x | +25.32% |
| 2020-12-31 | CN¥4.33 Billion ≈ $633.14 Million |
CN¥701.10 Million ≈ $102.59 Million |
0.162x | -28.45% |
| 2019-12-31 | CN¥4.09 Billion ≈ $598.12 Million |
CN¥925.73 Million ≈ $135.46 Million |
0.226x | +38.52% |
| 2018-12-31 | CN¥3.89 Billion ≈ $569.56 Million |
CN¥636.39 Million ≈ $93.12 Million |
0.164x | +53.44% |
| 2017-12-31 | CN¥3.59 Billion ≈ $525.84 Million |
CN¥382.93 Million ≈ $56.03 Million |
0.107x | +14.25% |
| 2016-12-31 | CN¥3.21 Billion ≈ $469.11 Million |
CN¥299.02 Million ≈ $43.76 Million |
0.093x | -47.99% |
| 2015-12-31 | CN¥2.87 Billion ≈ $420.08 Million |
CN¥514.80 Million ≈ $75.33 Million |
0.179x | +47.14% |
| 2014-12-31 | CN¥2.56 Billion ≈ $374.06 Million |
CN¥311.54 Million ≈ $45.59 Million |
0.122x | -39.25% |
| 2013-12-31 | CN¥1.93 Billion ≈ $283.08 Million |
CN¥388.11 Million ≈ $56.79 Million |
0.201x | +56.12% |
| 2012-12-31 | CN¥1.65 Billion ≈ $241.54 Million |
CN¥212.11 Million ≈ $31.04 Million |
0.129x | +110.14% |
| 2011-12-31 | CN¥1.47 Billion ≈ $215.81 Million |
CN¥90.19 Million ≈ $13.20 Million |
0.061x | -54.27% |
| 2010-12-31 | CN¥1.24 Billion ≈ $182.08 Million |
CN¥166.40 Million ≈ $24.35 Million |
0.134x | +759.34% |
| 2009-12-31 | CN¥1.08 Billion ≈ $157.77 Million |
CN¥-21.87 Million ≈ $-3.20 Million |
-0.020x | -133.16% |
| 2008-12-31 | CN¥954.72 Million ≈ $139.71 Million |
CN¥58.39 Million ≈ $8.54 Million |
0.061x | -63.20% |
| 2007-12-31 | CN¥557.95 Million ≈ $81.65 Million |
CN¥92.73 Million ≈ $13.57 Million |
0.166x | -24.83% |
| 2006-12-31 | CN¥492.91 Million ≈ $72.13 Million |
CN¥108.98 Million ≈ $15.95 Million |
0.221x | -0.20% |
| 2005-12-31 | CN¥457.89 Million ≈ $67.00 Million |
CN¥101.44 Million ≈ $14.84 Million |
0.222x | +323.09% |
| 2004-12-31 | CN¥414.10 Million ≈ $60.60 Million |
CN¥21.68 Million ≈ $3.17 Million |
0.052x | +14.61% |
| 2003-12-31 | CN¥374.88 Million ≈ $54.86 Million |
CN¥17.13 Million ≈ $2.51 Million |
0.046x | +36.56% |
| 2002-12-31 | CN¥333.38 Million ≈ $48.78 Million |
CN¥11.15 Million ≈ $1.63 Million |
0.033x | -88.24% |
| 2001-12-31 | CN¥73.91 Million ≈ $10.82 Million |
CN¥21.02 Million ≈ $3.08 Million |
0.284x | -- |
About Jiangsu Kanion Pharmaceutical Co Ltd
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 a… Read more